Owens & Minor (NYSE:OMI) Issues FY 2024 Earnings Guidance

Owens & Minor (NYSE:OMI - Get Free Report) updated its FY 2024 earnings guidance on Monday. The company provided earnings per share guidance of 1.500-1.530 for the period, compared to the consensus earnings per share estimate of 1.510. The company issued revenue guidance of $10.7 billion-$10.7 billion, compared to the consensus revenue estimate of $10.7 billion. Owens & Minor also updated its Q4 2024 guidance to 0.520-0.550 EPS.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on OMI shares. Robert W. Baird reduced their price target on shares of Owens & Minor from $15.00 to $14.00 and set a "neutral" rating on the stock in a report on Tuesday. UBS Group decreased their price objective on Owens & Minor from $28.00 to $25.00 and set a "buy" rating on the stock in a report on Tuesday, November 5th. Barclays cut their target price on shares of Owens & Minor from $18.00 to $14.00 and set an "equal weight" rating for the company in a report on Tuesday, November 5th. Finally, Citigroup dropped their price objective on shares of Owens & Minor from $21.00 to $18.50 and set a "buy" rating for the company in a research note on Tuesday, November 5th. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat, Owens & Minor has a consensus rating of "Hold" and a consensus price target of $18.50.

Owens & Minor Trading Down 2.5 %

NYSE:OMI traded down $0.22 during mid-day trading on Thursday, hitting $8.68. 943,329 shares of the stock traded hands, compared to its average volume of 948,265. Owens & Minor has a 52 week low of $8.58 and a 52 week high of $28.35. The company has a quick ratio of 0.45, a current ratio of 1.09 and a debt-to-equity ratio of 2.11. The stock has a market capitalization of $669.31 million, a price-to-earnings ratio of -13.20, a PEG ratio of 0.40 and a beta of 0.48. The firm's 50 day moving average is $13.60 and its two-hundred day moving average is $14.20.

Owens & Minor (NYSE:OMI - Get Free Report) last announced its quarterly earnings results on Monday, November 4th. The company reported $0.42 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.41 by $0.01. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. The firm had revenue of $2.72 billion during the quarter, compared to analyst estimates of $2.68 billion. During the same quarter in the previous year, the business earned $0.44 earnings per share. Owens & Minor's quarterly revenue was up 5.0% on a year-over-year basis. On average, equities research analysts predict that Owens & Minor will post 1.49 earnings per share for the current year.

Insider Activity

In other Owens & Minor news, CFO Jonathan A. Leon sold 5,282 shares of the stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $11.82, for a total transaction of $62,433.24. Following the sale, the chief financial officer now owns 130,822 shares of the company's stock, valued at approximately $1,546,316.04. This trade represents a 3.88 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 2.62% of the company's stock.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.